Company / Operating Margin
Zenas BioPharma, Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-3830.6%
FY2025
5-year range
-3830.6% / -74.3%
FY2023-FY2025
Trend
-5056.2%
vs FY2024
Sector context
#129 of 136
Health Care
What the data says
Operating Margin changed -5056% YoY in FY2025, a notable deviation from the 2-year average annual change of -2528%.
Based on SEC 10-K filings.
-3830.6% in FY2025.
Declined from -74.3% to -3830.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 136This company -3830.6% Sector average -778.9%
▼
-391.8% below sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 5056.2% year-over-year.
- Currently 3051.6pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3830.6% | -5056.2% |
| FY2024 | -74.3% | +0.0% |
| FY2023 | -74.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026